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Background: Monocyte chemoattractant protein-1 (MCP-1) is a major chemokine that recruits monocyte/macrophage
to the site of tissue injury and plays a critical role in microvascular complications of diabetes. However, the mechanisms
underlying the regulation of MCP-1 are not fully understood. The present study aims to explore the role of activating
transcription factor 4 (ATF4), an ER stress-inducible transcription factor, in regulation of MCP-1 expression and production
in brain and retinal microvascular endothelial cells.
Methods: For in vitro study, primary brain microvascular endothelial cells isolated from ATF4 knockout mice or mouse
retinal endothelial cells were treated with lipopolysaccharide (LPS) to induce MCP-1 expression. ATF4 expression/function
was manipulated by adenoviruses expressing wild type ATF4 (Ad-ATF4) or a dominant negative mutant of the protein
(Ad-ATF4DN). For in vivo study, MCP-1 expression was induced by intravitreal injection of LPS or Ad-ATF4 in heterozygous
ATF4 knockout or wild type mice.
Results: LPS treatment induced a dose- and time-dependent increase in ATF4 expression, ER stress and MCP-1
production in brain and retinal microvascular endothelial cells. Overexpression of ATF4 in endothelial cells significantly
increased the secretion of MCP-1 and promoted THP-1 monocyte-endothelial cell adhesion. Conditioned medium from
ATF4-overexpressiing endothelial cells significantly enhanced THP-1 cell migration. Consistently, intravitreal injection of
Ad-ATF4 remarkably enhanced retinal levels of MCP-1 and promoted inflammatory cell infiltration into the vitreous and
retina. In contrast, LPS-induced MCP-1 upregulation was markedly attenuated in ATF4-deficient endothelial cells and in
retinas of ATF4 knockout mice, suggesting that ATF4 is essential for LPS-induced MCP-1 production in endothelial cells
and in the retina. Mechanistically, overexpression of ATF4 enhanced, while inhibition of ATF4, attenuated the basal and
LPS-stimulated phosphorylation of NF-κB, P38, and JNK. Furthermore, pharmacological inhibition of NF-κB, P38, or JNK
significantly reduced ATF4-stimulated MCP-1 secretion from endothelial cells.
Conclusions: Taken together, our results suggest a critical role of ATF4 in the regulation of MCP-1 production in retinal
and brain microvascular endothelial cells, which may contribute to inflammation-related endothelial injury in diseases
such as diabetic retinopathy.
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The endoplasmic reticulum (ER) is the central hub for
protein biosynthesis, protein folding and regulation of
intracellular calcium concentration. A delicate balance
between protein synthesis and folding is vital for cell
survival and function. However, this homeostasis can be* Correspondence: xzhang38@buffalo.edu
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conditions, due to increased demand of protein produc-
tion, reduced capacity of protein folding, altered redox
status in the ER, or perturbed protein and calcium traf-
ficking [1]. As a consequence, unfolded or misfolded
proteins accumulate in the ER, resulting in activation of
the unfolded protein response (UPR) by three ER mem-
brane proteins: inositol requiring trans-membrane kinase/
endonuclease 1 (IRE1), activating transcription factor 6
(ATF6) and protein kinase (PKR)-like endoplasmic reticulum
kinase (PERK). PERK, through phosphorylation of eukaryoticThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tein translation but increases the production of activating
transcription factor 4 (ATF4), inducing the expression
of C/EBP homologous protein (CHOP) [2]. Chronic ER
stress results in apoptosis and cell death, contributing
to retinal degeneration [3]. In addition, our recent stud-
ies have shown that ER stress and the PERK/eIF2α/
ATF4/CHOP pathway are involved in regulation of im-
mune response and retinal vascular injury in diabetic
retinopathy, a common complication of diabetes [4,5].
However, the mechanisms underlying ER stress-related
inflammatory signaling are not fully understood.
The innate immune system is a critical component of
host defense, which recognizes pathogen-associated mole-
cules through pathogen-recognition receptors, such
as Toll-like receptors (TLRs) [6]. TLR4 recognizes
specific structural components of pathogens, such as
lipopolysaccharide (LPS), resulting in the activation
of MyD88-dependent and TRIF-dependent pathways.
The MyD88-dependent pathway primarily activates
signaling proteins including TGF-beta-activated kinase
(TAK)-nuclear factor (NF)-κB and TAK-mitogen-activated
protein kinase (MAPK)-AP-1[7]. The activation of these
transcription factors induces the expression of multiple
pro-inflammatory factors, such as monocyte chemoat-
tractant protein-1 (MCP-1). Intriguingly, several studies
have revealed a role of ER stress and the UPR in regula-
tion of the TLR signaling [8,9]. In macrophages, induction
of the UPR acts synergistically with LPS in production of
cytokines such as interleukin 23 and interleukin 17
[10,11]. Moreover, activation of ATF4 has been shown
to promote the secretion of interleukin 6, interleukin 8
and RANTES through an interaction with c-Jun of the
TLR4-MyD88 pathway. Paradoxically, recent work by
Woo and colleagues indicates that pretreatment with low
dose of LPS selectively suppresses the PERK-ATF4-CHOP
pathway [12] and protects mice from tunicamycin-induced
renal dysfunction and hepatosteatosis [12]. These findings
indicate some complex interactions between the UPR and
TLR4 signaling, which may contribute to the tight control
of inflammatory factor expression during tissue injury.
In diabetic retinopathy, increased MCP-1 production is
a major factor responsible for leukocyte migration and
interaction with endothelium resulting in microvascular
injury of the retina. Previously we have shown that ATF4
was upregulated in diabetic retina and was required
for pro-inflammatory genes VEGF (vascular endothe-
lial growth factor) and ICAM-1 (intercellular adhe-
sion molecule 1) expression in Müller and vascular
endothelial cells [4,5]. In the present study, we inves-
tigated the role of ATF4 in MCP-1 production from
brain and retinal microvascular endothelial cells and
explored the underlying mechanisms by which ATF4
regulates MCP-1 expression.Materials and methods
Materials
Thapsigargin (TG) was obtained from Sigma-Aldrich
(St. Louis, MO). JNK inhibitor II (SP600125), P38 inhibitor
(SB203580), and p44/42 inhibitor (U0126) were purchased
from Calbiochem (San Diego, CA). NF-κB inhibitor
(Ro106-9920) was obtained from Tocris Bioscience.
Endothelial cell growth supplement kit was obtained
from Millipore (Billerica, MA). Protease inhibitor cocktail,
anti-ATF4, anti-CHOP, antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-
eIF2α, anti–eIF2α, anti-phospho-JNK, anti- phospho-P38,
anti-phospho-NF-κB, and anti- phospho-p44/42 antibodies
were obtained from Cell Signaling (Danvers, MA), and anti-
β-actin antibody was from Abcam (Cambridge, MA).
Horseradish peroxidase–conjugated, fluorescein isothio-
cyanate avidin (FITC)-conjugated, or biotinylated sec-
ondary antibodies, and DAPI were purchased from
Vector Laboratories (Burlingame, CA). Cy3-conjugated
anti-rabbit IgG was obtained from Jackson ImmunoRe-
search Laboratories (West Grove, PA).
Cell culture
Immortalized mouse retinal endothelial cells [13] were
grown at 33°C in DMEM with 10% FBS and 30 μg/ml
endothelial cell growth supplement. THP-1 cells were
obtained from ATCC (Manassas, VA) and were routinely
maintained in RPMI 1640 medium with 10% fetal bovine
serum and 0.05 mM 2-mercaptoethanol. Mouse brain
microvascular endothelial cells were isolated as described
previously [14] and were grown in DMEM with 20% FBS.
To better recapitulate the in vivo situation and to reduce
the confounding effects of the serum, subconfluent cells
were starved with DMEM containing 1% FBS to acquire
quiescence prior to the desired treatments.
Experimental animals
C57BL/6 J mice were purchased from the Jackson
Laboratory (BarHarbor,ME). ATF4 knockout mice were
kindly provided by Tim Townes, Ph.D. (University of
Alabama at Birmingham) [4,5]. Care, use, and treatment
of all animals were in strict agreement with the guide-
lines of the Association for Research in Vision and
Ophthalmology Statement for the Use of Animals in
Ophthalmic and Visual Research and approved by the
institutional animal care and use committees in the
University of Oklahoma Health Sciences Center.
Intravitreal injection of adenovirus
Intravitreal injection was performed in deeply anesthe-
tized mice using an UltraMicroPump (World Precision
Instruments, Sarasota, FL). Briefly, an incision was
made 1 mm behind the limbus with a sharp-edge 31-
gauge needle. The 34-gauge blunt needle mounted on
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cavity. One microliter of vehicle containing 109 viral
particles was delivered into the vitreous with one foot-
switch press.
Transduction of microvascular endothelial cells with
adenovirus
Adenoviruses expressing wild-type ATF4 (Ad-ATF4) or
a dominant negative mutant of ATF4 (Ad-ATF4DN) were
generated and propagated as described previously [4,5].
Empty adenoviruses that did not contain a transgene were
used as control. Retinal or brain microvascular endothelial
cells were transduced with adenoviruses at 30 MOI
(multiplicity of infection) (for immortalized mouse ret-
inal endothelial cells) or 100 MOI (for primary mouse
brain endothelial cells) for 24 h. Cells were then exposed
to DMEM containing 1% FBS overnight to acquire quies-
cence prior to the desired treatments.
Histology and immunofluorescence
For retinal histological study, eyeballs were immersed
in Per-fix (4% paraformaldehyde, 20% isopropanol, 2%
trichloroacetic acid, 2% zinc chloride) overnight and
embedded in paraffin. Sagittal sections of 5 μm thick-
ness were stained with hematoxylin and eosin (HE)
and examined under an Olympus microscopy (Tokyo,
Japan). Immunofluorescence study on retinal cryosec-
tions was prepared as previously described [11]. Briefly,
the sections were immunostained with anti-CD11b anti-
body (1:100 dilution) overnight at 4°C. Negative controls
without primary antibody incubation were included. After
multiple washes, the sections were incubated with Cy3-
conjugated secondary antibody (Molecular Probes, Eugene,
OR, USA). DAPI was used to label cell nuclei.Real-time qPCR
Total RNA was extracted using the RNeasy Mini Kit
(Qiagen). cDNA was synthesized using the iScript cDNA
Synthesis Kit, and Real-time qPCR was performed using
SYBR Green PCR Master Mix (Bio-Rad Laboratories,
Hercules, CA, USA) on an iCycler iQTM (BioRad,
Hercules, CA). Relative mRNA level was calculated by
the ΔΔCt method and ribosomal protein L19 (Rlp19)
was used as an endogenous control. The sequences of




The transwell migration assay was performed on semi-
permeable membranes with pore size of 5 μm (Costar
Transwell, Corning, NY). Briefly, THP-1 cells were sus-
pended in RPMI1640 medium supplemented with 1%FBS and 0.5% BSA (Sigma-Aldrich). 1 × 105 cells were
seeded in the transwell inserts and allowed to migrate
overnight toward the lower compartments with the con-
ditioned medium from endothelial cell culture. The
membranes of the inserts were fixed with 4% parafor-
maldehyde. Cells on the top surface of the membrane
were mechanically removed, and those migrated to the
bottom of the membrane were stained with DAPI (4’, 6-
diamidino-2-phenylindole). Cell numbers were counted
in 3 random visual fields, using an Olympus fluores-
cence microscope (Tokyo, Japan).
Leukocyte adhesion assay
Endothelial cells were grown to 80% confluence in six-
well plates and pretreated with LPS or Ad-ATF4 with
controls for 24 h. THP-1 cells were added to endothelial
culture and incubated for additional 3 h. Unbound THP-1
cells were removed by 3 washes with PBS, and bound
THP-1 monocytes were counted from 3 random visual
fields under an Olympus microscope (Tokyo, Japan).
Western blot analysis
Cells or retina tissue were lysed in radioimmunopreci-
pitation assay lysis buffer (RIPA, Santa Cruz). Western
blot analysis was performed as described previously
[4,5]. The following primary antibodies were used at
the indicated dilutions: anti-phospho-eIF2α (1:1,000),
anti-eIF2α (1:1,000), anti-ATF4 (1:500), anti-CHOP
(1:500), anti-phospho-JNK (1:500), anti-phospho-p38
(1:1000), antiphospho-p44/42(1:1000), anti-phospho-NF-κB
(1:1000), and anti-β-actin (1:5,000) antibodies. Horseradish
peroxidase-conjugated goat-anti-rabbit IgG (Vector
Laboratories, Bulingame, CA) and goat anti-mouse IgG
(Vector Laboratories) were used as secondary antibodies.
ELISA
MCP-1 was quantified using mouse MCP-1 ELISA assay
kit (R&D systems, Minneapolis, MN) according to man-
ufacturer’s instructions.
Statistical analysis
Statistical analysis was performed using Student’s t test
when comparing two groups, or ANOVA with Bonferroni’s
post hoc test when comparing three or more groups. Statis-
tical significance was accepted as p < 0.05.
Results
LPS increases ER stress and ATF4 expression in
microvascular endothelial cells
We first examined whether activation of the TLR4
signaling by LPS induces ER stress and ATF4 expression
in mouse brain and retina microvascular endothelial cells.
Our results show that 31.25 ng/mL to 500 ng/mL of LPS
significantly increased ATF4 levels in a dose-dependent
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observed in cells treated with 250 ng/ml of LPS. To deter-
mine the time course of ATF4 induction, cells wereFigure 1 LPS increases ER stress and ATF4 expression in mouse microvascu
with 31.25 ng/ml - 250 ng/ml of LPS for 24 h or treated with 250 ng/ml of LP
and quantified by densitometry. B). Mouse retinal endothelial cells were treat
eIF2α, ATF4, and CHOP were analyzed. C). Mouse brain endothelial cells were
and total eIF2α, ATF4, and CHOP were examined. D-E). Mouse retinal end
levels of MCP-1 were determined by qPCR (D). The levels of MCP-1 in the
mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P <0.001 vs. control.exposed to LPS (250 ng/ml) for 0–48 h. Western blot ana-
lysis shows that the levels of ATF4 increased at 12 h, con-
tinued to increase at 24 h, and slightly declined at 48 hlar endothelial cells. A). Mouse retinal endothelial cells were treated
S for 0–48 h. The levels of ATF4 were determined by western blot analysis
ed with 250 ng/ml of LPS for 24 h, the levels of phosphorylated and total
treated with 250 ng/ml of LPS at for 8 h. The levels of phosphorylated
othelial cells were treated with 250 ng/ml of LPS for 24 h. The mRNA
medium were measured by ELISA (E). Results were expressed as
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significantly increased the levels of ATF4-related ER stress
markers, including eIF2α phosphorylation andCHOP in both
retinal (Figure 1B) and brain (Figure 1C) endothelial cells,
and the inductions appeared to be more profound in brain
endothelial cells than retinal endothelial cells. Moreover, LPS
treatment markedly increased MCP-1 mRNA expression
(Figure 1D) and protein secretion (Figure 1E). The temporal
correlations suggest a potential role of ER stress and ATF4 in
MCP-1 production inmicrovascular endothelial cells.
ATF4 mediates LPS-induced MCP-1 production in
microvascular endothelial cells
Previously we have shown that ATF4 is required for the
expression of two major pro-inflammatory genes, VEGF
and ICAM-1, in retinal Müller and endothelial cells [4,5,15].
In order to elucidate if ATF4 mediates LPS-induced MCP-1Figure 2 ATF4 mediates LPS-induced MCP-1 production in mouse microva
transduced with Ad-ATF4, Ad-ATF4DN, or Ad-Ctrl for 24 h and then treated
expression and protein secretion were measured by qPCR or ELISA, respect
stimulated with 250 ng/ml of LPS for 8 h. MCP-1 secretion in the medium
were transduced with Ad-Ctrl or Ad-ATF4 and then treated with 250 ng/m
expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** p < 0.001 vs. Ad-Ctrl; ++production from endothelial cells, gain-of-function and
loss-of-function experiments were performed using adeno-
viruses expressingwild typeATF4 (Ad-ATF4)or itsdominant
negative form (Ad-ATF4DN). The efficiency of adenoviral
transduction and protein expression in mouse retinal
endothelial cells were confirmed in Figure 2A. Following
viral transduction, cells were incubated with 250 ng/ml of
LPS for 24 h. The levels of MCP-1 mRNA expression and
protein secretion were measured by real-time PCR and
ELISA, respectively. Our results show that overexpression
of ATF4 resulted in a 2.8-fold increase in MCP-1 mRNA
and significantly enhanced LPS-induced MCP-1 expression
(Figure 2B). Inhibition of ATF4 did not alter the basal level
of MCP-1 but reduced LPS-stimulated MCP-1 expression
by 40% (Figure 2C). At protein level, treatment with Ad-
ATF4 or LPS alone induced a 2-fold increase in MCP-1 se-
cretion (Figure 2D). Combination of Ad-ATF4 and LPSscular endothelial cells. A-D). Mouse retina endothelial cells were
with 250 ng/ml of LPS for extra 24 h. The levels of MCP-1 mRNA
ively. E). ATF4 +/+ or ATF4 −/− mouse brain endothelial cells were
was evaluated by ELISA. F). ATF4+/+ mouse brain endothelial cells
l of LPS for 8 h. MCP-1 secretion was measured by ELISA. Results were
P < 0.01, +++ P < 0.001 vs. WT + LPS or Ad-Ctrl + LPS.
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synergistic effect of ATF4 and LPS in MCP-1 secretion.
Inhibition of ATF4 activity reduced LPS-stimulated MCP-1
secretion by 37% (Figure 2D). In line with these results,
brain endothelial cells isolated from ATF4 −/− mice
showed a 40% reduction in MCP-1 secretion when chal-
lenged with LPS, compared to ATF4 +/+ endothelial
cells (Figure 2E). Interestingly, overexpression of ATF4
induced a 4-fold increase in MCP-1 secretion in brainFigure 3 ATF4 regulates retinal MCP-1 expression and leukocyte infiltration
received intravitreal injection of 250 ng of LPS in one eye and PBS as contr
MCP-1 expression was determined by qPCR (n = 5). Results were expressed
C57/B6J mice received intravitreal injection of 1 μl of Ad-ATF4 or Ad-Ctrl (1
was measured by ELISA (B). Results are expressed as mean ± SD, n = 5. *P <
analyzed by H&E staining of paraffin sections (C). and immunofluorescence
cell layer, INL: inner nuclear layer, ONL: outer nuclear layer. Black arrows ind
arrows indicate CD11b positive cells in the retina (D). Images were represeendothelial cells (Figure 2F). These results indicate that
ATF4 is both sufficient and essential for LPS-induced
MCP-1 production in microvascular endothelial cells.
ATF4 regulates retinal MCP-1 expression and leukocyte
infiltration in vivo
To confirm the in vitro results, we conducted two inde-
pendent sets of experiments with wild type (WT) and
heterozygous ATF4 knockout (KO) mice. As describedin vivo. A). Wild type (WT) or heterozygous ATF4 knockout (KO) mice
ol in the contralateral eye. Twenty-four hours after injection, retinal
as mean ± SD. *P < 0.05 vs. WT + PBS; ++ P < 0.01 vs. WT + LPS. B-D).
09 viral particles). After 5 days, retinas were harvested and MCP-1 level
0.05 vs. Ad-Ctrl. Leukocyte infiltration into the vitreous and retina was
analysis for monocyte/macrophage marker CD11b (D). GCL: ganglion
icate inflammatory cell infiltration into the vitreous (C) and white
ntative of 3 mice in each group.
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able for eye experiment due to the defect in the devel-
opment of the lens [4,5]. In the first experiment, 250 ng
of LPS was injected into the vitreous cavity of one eye
of a mouse and equal volume of PBS was injected into
the contralateral eye as control. Retinal MCP-1 expres-
sion was determined by real-time qPCR at 24 h post-
injection. Our results show that LPS induced over 20
fold increase in MCP-1 expression in WT mice and, to
a significantly less extent (5 fold increase) in ATF4 KO
mice (Figure 3A). In addition, the basal MCP-1 expression
was reduced in the retina of ATF4 KO mice, suggesting
ATF4 is essential for retinal MCP-1 expression in both
static and stimulated conditions. In the second experi-
ment, we overexpressed ATF4 in the retina by intravitreal
injection of Ad-ATF4 in C57/BL6J mice. We found that
overexpression of ATF4 resulted in a 3-fold increase in
retinal MCP-1 production when compared to control
(Figure 3B). Furthermore, we observed a large number of
leukocytes accumulating in the vitreous and the retina,
predominantly in the area around the optic nerve head,
in the eyes injected with Ad-ATF4 (Figure 3C). These
changes were further confirmed by increased expression
of CD11b, a surface marker of leukocytes [16], in the
retina after Ad-ATF4 treatment (Figure 3D). TakenFigure 4 Effects of conditioned medium derived from endothelial cells ov
endothelial cells were transduced with Ad-Ctrl or Ad-ATF4 for 24 h. B). Brai
challenged with 250 ng/ml LPS for 24 h. The medium was collected from end
in the Method section. Left panels: representative images of migrated THP-1 c
from 3 independent experiments. Results are expressed as mean ± SD (n = 3).together, these results suggest a critical role of ATF4 in
LPS-induced retinal MCP-1 production and leukocyte
infiltration.
Manipulating ATF4 expression in endothelial cells
influences leukocyte migration and leukocyte-endothelial
adhesion
MCP-1 is considered a key regulator of monocyte adhe-
sion, migration and recruitment. We hypothesize that
ATF4 regulates MCP-1 secretion from retinal endothe-
lial cells, which in turn promotes monocyte/macrophage
adhesion and migration into retinal tissue resulting in in-
flammation. To test this hypothesis, retinal and brain
endothelial cells were transduced with Ad-ATF4 or treated
with 250 ng/ml of LPS for 24 h. Conditioned medium was
collected from endothelial culture and added to cultured
THP-1 cells. After 24 h of incubation, THP-1 cells were
subjected to migration assay. Results show that incubation
with the conditioned medium from ATF4-overexpressing
endothelial cells significantly enhanced THP-1 cell migra-
tion (Figure 4A). Likewise, incubation with the medium
from LPS-challenged wild type (ATF4 +/+) endothelial cells
also induced a robust increase in THP-1 cell migration.
This effect was markedly reduced in the cells incubated
with the medium from LPS-treated ATF4−/− endothelialerexpressing or lacking ATF4 on THP-1 cell migration. A). Mouse retinal
n endothelial cells isolated from ATF4 +/+ or ATF4 −/− mice were
othelial cell culture and used for THP-1 cell migration assay as described
ells (200×). Right panels: The numbers of migrated cells were quantified
** P < 0.01 vs. Ad-Ctrl or WT; ++ p < 0.01 vs. WT + LPS.
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stimulated inflammatory factor secretion from endothelial
cells. In contrast, conditioned medium from unstimulated
ATF4 +/+ or ATF4 −/− endothelial cells had negligible ef-
fect on THP-1 migration.
Next, we investigated whether manipulation of ATF4
expression in endothelial cells affects monocyte-endothelial
adhesion. Prior to the adhesion assay, retinal endothelial
cells were transduced with Ad-ATF4 or control adenovirus
for 24 h. ATF4 +/+ or ATF4 −/− brain endothelial cells
were pre-treated with LPS for 24 h. Endothelial-monocyte
adhesion assay was performed as described in the Method
section. Results show that overexpressing ATF4 in endo-
thelial cells significantly increased monocyte-endothelial
adhesion (Figure 5A). LPS treatment of ATF4 +/+
endothelial cells also resulted in an over 10-fold increase
in THP-1 adhesion, which was markedly reduced in
ATF4 −/− cells (Figure 5B). Unstimulated ATF4 +/+
and ATF4 −/− endothelial cells demonstrated similar
capability in inducing THP-1 adhesion. These results
strongly suggest a critical role of endothelial ATF4 in
promoting monocyte migration and adhesion to endo-
thelial cells.Figure 5 Overexpressing/suppressing ATF4 in endothelial cells promotes/i
transduced with Ad-Ctrl or Ad-ATF4 for 24 h. THP-1 cells were added and c
counted from 5 random visual fields. B). Brain endothelial cells isolated from
24 h. THP-1 monocyte adhesion was assessed as described in (A). Images a
as mean ± SD (n = 3). ** P < 0.01 vs. Ad-Ctrl or WT; ++ p < 0.01 vs. WT + LPSATF4 up-regulates MCP-1 through NF-κB and MAPK
pathways
NF-κB and AP-1 are key transcription factors in
LPS-activated TLR4/MyD88 pathway that upregulate
inflammatory genes, such as MCP-1. To elucidate
the mechanisms by which ATF4 promotes MCP-1 ex-
pression, we evaluated the effects of ATF4 on NF-κB and
MAPK activation. In retinal endothelial cells, inhibition of
ATF4 by Ad-ATF4DN significantly reduced both the basal
and LPS-stimulated phosphorylation of NF-κB, P38, and
JNK, but did not alter the phosphorylation of P44/42
(Figure 6A). In contrast, overexpression of ATF4 in-
creased phosphorylation of NF-κB, P38 and JNK, but
not P44/42 (Figure 6B). LPS treatment further enhanced
phosphorylation of NF-κB and MAPKs, indicating a
synergistic effect of LPS treatment and overexpression
of ATF4 on activation of these pathways.
In brain microvascular endothelial cells, LPS induced
a much less increase in NF-κB, P38 and JNK activation
in ATF4–deficient cells (Figure 7A). These results have
further confirmed the findings from retinal endothelial
cells that inhibition of ATF4 reduces the activation of
NF-κB, P38 and JNK pathways. To clarify the roles ofnhibits THP-1 cell adhesion. A). Mouse retinal endothelial cells were
o-cultured for 3 hours. Adherent monocytes to endothelial cells were
ATF4 +/+ or ATF4−/− mice were challenged with 250 ng/ml LPS for
re representatives of 3 independent experiments. Results are expressed
.
Figure 6 ATF4 is required for LPS-induced NF-κB and MAPK activation in retinal endothelial cells. Mouse retina endothelial cells were transduced
with Ad-Ctrl, Ad-ATF4DN (A), or Ad-ATF4 (B) for 24 h and then treated with 250 ng/ml LPS for additional 8 h. The levels of p-NF-κB, p-P38, p-JNK,
p-P42/44 were determined by western blot analysis and quantified by densitometry. Results are expressed as mean ± SD (n = 3). * P < 0.05,
** P < 0.01 vs. Ad-Ctrl; + P < 0.05, ++ P < 0.01 vs. Ad-Ctrl + LPS.
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Figure 7 ATF4 regulates MCP-1 expression through enhancing
NF-κB and MAPK activation. A). Brain endothelial cells from ATF4 +/+
and ATF4 −/− mice were treated with 250 ng/ml LPS for 8 h. The levels
of p-NF-κB, p-P38, p-JNK, p-P42/44 were determined by western blot
analysis and quantified by densitometry (mean ± SD, n = 3). *P < 0.05
vs. WT; +P < 0.05, ++P < 0.01 vs. WT + LPS. B). Brain endothelial cells from
ATF4 +/+ mice were pretreated with 1 μM Ro106, 10 μM SB203580,
10 μM SP600125 or 10 μM U0126 for 1 h, followed by transduction
with Ad-ATF4 or Ad-Ctrl for 24 h. MCP-1 protein levels in the
media were measured by ELISA. Results are expressed as
mean ± SD (n = 3). ** P < 0.01 vs. Ad-Ctrl; + P < 0.05, ++ P < 0.01
vs. Ad-ATF4.
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upregulation, brain endothelial cells were pretreated
with pharmacological inhibitors of NF-κB, P38, JNK,
and P44/42 and then transduced with Ad-ATF4 or Ad-
Ctrl. Pretreatment with inhibitors of NF-κB, P38, JNK,
but not P44/42, significantly reduced MCP-1 secretioninduced by Ad-ATF4 (Figure 7B). These results suggest
that the activation of NF-κB, P38, and JNK is involved
in ATF4-induced MCP-1 production.
Discussion
We have previously shown that ATF4 is involved in the
regulation of inflammatory genes in retinal endothelial
and Müller cells [4,5]. However, the mechanisms are
not fully defined. Herein, we demonstrate that ATF4 is
essential for MCP-1 expression in endothelial cells,
likely through promoting the activation of NF-κB and
MAPK pathways. ATF4 is a major stress response gene
activated in cells under conditions of ER stress and oxida-
tive stress [4,5,17-20]. As a transcription factor, ATF4 reg-
ulates a variety of genes involved in multiple biological
processes, including hematopoiesis, lens and skeletal de-
velopment, inflammation, angiogenesis, oxidative stress,
and apoptosis. Recently studies suggest that ATF4 is
up-regulated in various pathogen-induced-immune re-
sponses and participates in the TLR signaling pathways
[12,21-23]. Coincidently, other UPR branches are also
activated, reflecting the concurrence of ER stress with
ATF4 activation [24-29]. Moreover, activation of ATF4
enhances TLR4-induced secretion of pro-inflammatory
cytokines (IL-6 and IL-8) in macrophages [30]. In line
with these findings, we show that activation of TLR4 by
LPS induces ER stress and upregulates ATF4 in brain
and retinal microvascular endothelial cells. Over-expression
of ATF4 was sufficient to induce MCP-1 expression. In
contrast, inhibition of ATF4 significantly attenuated
LPS-induced MCP-1 secretion. These observations
support our previous findings that ATF4 is an import-
ant regulator of retinal inflammatory response and vas-
cular leakage in diabetic retinopathy [5] and further
reveals a role of MCP-1 in ATF4-mediated retinal
inflammation.
MCP-1 is a key chemokine that regulates monocyte/
macrophage migration and recruitment in inflamma-
tory tissues [31-34]. Herein, we provided several lines
of evidence that support a critical role of ATF4 in regu-
lation of MCP-1 production and inflammatory cell
infiltration. First, we found the MCP-1 level was in-
creased in the medium from ATF4-overexpressing
endothelial cells, and both adhesion and migration of
THP-1 cells were enhanced when incubated with this
conditioned medium. Second, using the medium from
ATF4-deficient endothelial cells impaired monocyte
adhesion and migration, even in the presence of LPS. A
limitation of these experiments is using THP-1 cells, a
human monocyte cell line, to investigate adhesion to
murine endothelial cells. Although THP-1 cells have
been extensively used for adhesion and migration assays,
future studies using murine J774 cells to confirm the
results from the current study is necessary. Third, over-
Huang et al. Journal of Inflammation  (2015) 12:31 Page 11 of 12expression of ATF4 in vivo promoted macrophage infiltra-
tion into the vitreous and retina. These findings indicate
that ATF4 is involved in MCP-1 regulation in endothelial
cells, which in turn modulates monocyte/macrophage
activity and retinal inflammatory response. It is notable
that although MCP-1 is abundant in the endothelial
culture supernatant, there are likely other secreted
factors that are regulated by ATF4 and contribute to
macrophage migration. Future studies to eliminate or
deactivate MCP-1 protein by applying a neutralising
antibody against MCP-1 to the conditioned medium or
using supernatant from MCP1-null endothelial cells
engineered to overexpress ATF4 are warranted to clar-
ify the role of MCP-1 in mediating the effect of ATF4
upregulation in endothelial cells on macrophage adhe-
sion and infiltration.
LPS activation of the TLR4 signaling, through MyD88-
downstream NF-κB and AP-1 pathways, leads to the in-
duction of pro-inflammatory cytokines including MCP-1
[35,36]. Recent studies found that upon LPS stimulation,
ATF4 forms dimer with JNK via the AP-1 and CREB
binding sites, promoting the secretion of various pro-
inflammatory cytokines in human monocytes/macrophages
[30]. Our previous work also indicates a crosstalk between
ATF4 and classic inflammatory signals including STAT3
and JNK in retinal endothelial and Müller cells, respect-
ively [4,5]. Now, we demonstrate that deletion of ATF4
or inhibition of ATF4 function significantly attenuates
the basal and LPS-stimulated phosphorylation of NF-
κB, P38, and JNK. In contrast, overexpressing ATF4 is
sufficient to activate these signaling molecules, which
are required for ATF4-mediated MCP-1 expression.
These results have revealed a new mechanism by which
ATF4 interacts with TLR4 pathways through activation
of MyD88 downstream effectors and, thus, might be a
central coordinator for inflammatory response in micro-
vascular endothelial cells in the brain and the retina.
Conclusions
Our data suggest that ATF4 functions as a positive
regulator in LPS-triggered MCP-1 production in endo-
thelial cells through multiple pathways. This mechan-
ism could reveal a new target in endothelial cells to
prevent vascular pathology associated with monocyte/
macrophage-mediated inflammation in diseases such as
diabetic microvascular complications.
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